tirzepatide 2.5 mg/0.5ml solution auto-injector Zepbound vs. Mounjaro: A Comparison for Weight Management and Diabetes Control Mounjaro (Tirzepatide) 2.5mg/0.5mL Pre-Filled Pen

A study presented at ENDO 2025 found that people taking semaglutide who consumed higher amounts of protein lost significantly less muscle mass than those who did not prioritize their nutrition

The STEP trials showed sustained weight loss maintenance when patients remained on therapy, with some individuals achieving even greater reductions through consistent dosing and lifestyle support

The drug won a priority review voucher from the agency, which could mean the agency will make a decision "within months." Novo Nordisk and Eli Lilly are also working on the next generation of these drugs, which could prove to be even more effective than the ones already on the market

A subgroup analysis showed no significant interaction between age and treatment effect within the premenopausal population, meaning that a 32-year-old and a 47-year-old derived comparable benefit at the same 1.75 mg dose [1]